ACS applied materials & interfaces

Nature communications

Heliyon

international journal of nanomedicine

Medicine

The European respiratory journal

materials science & engineering c, materials for biological applications

Journal of colloid and interface science

The Journal of antimicrobial chemotherapy

Biochemical and biophysical research communications

Pharmaceutics

The American surgeon

international journal of clinical oncology

european journal of pharmaceutics and biopharmaceutics : official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik ev

journal of clinical pharmacy and therapeutics

drug development and industrial pharmacy

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

lung india : official organ of indian chest society

[1] Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.

[2] Comparative effectiveness of 3 Traditional Chinese Medicine treatment methods for idiopathic pulmonary fibrosis: A systematic review and network meta-analysis protocol.

[3] Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey.

[4] Paclitaxel-loaded sodium deoxycholate-stabilized zein nanoparticles: characterization and cytotoxicity.

[5] High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.

[6] Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX).

[7] Ultrafast Synthesizing Bismuth Mesoporous Nanolitchi Radiosensitizer Loading High Dose DOX for CT Guided Enhanced Chemoradiotherapy.

[8] Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.

[9] Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with Naringin.

[10] Paclitaxel-induced dermal hypersensitivity lesions: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography.

[11] Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.

[12] Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.

[13] Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?

[14] Stimuli-sensitive fatty acid-based microparticles for the treatment of lung cancer.

[15] An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy.

[16] astrocyte activation in the anterior cingulate cortex and altered glutamatergic gene expression during paclitaxel-induced neuropathic pain in mice

[17] in vitro anticancer drug test: a new method emerges from the model of glioma stem cells

[18] paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract

[19] styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model

[20] cardioprotective efficiency study of combination of pyrimidine and 3-hydroxypyridine derivatives in experimental antitumor chemotherapy

[21] vitrification of mouse mii oocytes: developmental competency using paclitaxel

[22] nonconvulsive status epilepticus secondary to paclitaxel administration

[23] myeloprotective efficiency of combination of pyrimidine and 3-hydroxypyridine derivatives in experimental antineoplastic chemotherapy

[24] electrochemical behavior of paclitaxel and its determination at glassy carbon electrode

[25] lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to c6 glioma cells with p-gp inhibition and its tumor targeting

[26] human albumin fragments nanoparticles as ptx carrier for improved anti-cancer efficacy

[27] effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study

[28] Dual drug delivery system of RAPTA-C and paclitaxel based on fructose coated nanoparticles for metastatic cancer treatment.

[29] Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.

[30] PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy.

[31] Antitumor Activity of 1,18-Octadecanedioic Acid-Paclitaxel Complexed with Human Serum Albumin.

[32] Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study

[33] A rare case of generalized tonic-clonic seizure related to paclitaxel infusion.

[34] The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4.

[35] MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.

[36] Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.

[37] Endoscopic Ultrasound-Guided Drainage of Intra-Abdominal Abscess after Gastric Perforation in a Patient Receiving Ramucirumab and Paclitaxel for Advanced Gastric Cancer

[38] Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles

[39] Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer

[40] Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.

[41] Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis.

[42] Paclitaxel-loaded sodium deoxycholate-stabilized zein nanoparticles: characterization and cytotoxicity.

[43] High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.

[44] Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX).

[45] QbD-Based Development of Cationic Self-nanoemulsifying Drug Delivery Systems of Paclitaxel with Improved Biopharmaceutical Attributes.

[46] Corrigendum to “Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy” (Materials Science & Engineering C (2019) 102 (113–123), (S0928493118320290), (10.1016/j.msec.2019.03.009))

[47] Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project

[48] Potentiation of Paclitaxel-Induced Pain Syndrome in Mice by Angiotensin I Converting Enzyme Inhibition and Involvement of Kinins.

[49] Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with Naringin.

[50] Entropically driven controlled release of paclitaxel from poly(2-ethyl-2-oxazoline) coated maghemite nanostructures for magnetically guided cancer therapy.

[51] Poly-paclitaxel/cyclodextrin-SPION nano-assembly for magnetically guided drug delivery system

[52] Tissue-specific study across the stem of Taxus media identifies a phloem-specific TmMYB3 involved in the transcriptional regulation of paclitaxel biosynthesis.

[53] Downregulation of GPSM2 is associated with primary resistance to paclitaxel in breast cancer.

[54] Paclitaxel-induced dermal hypersensitivity lesions: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography.

[55] Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.

[56] Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.

[57] Glycol chitosan in situ coating on PLGA nanoparticle curtails extraneous paclitaxel precipitates and imparts protein corona independent hemocompatibility

[58] Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes

[59] astrocyte activation in the anterior cingulate cortex and altered glutamatergic gene expression during paclitaxel-induced neuropathic pain in mice

[60] albumin-bound formulation of paclitaxel (abraxane® abi-007) in the treatment of breast cancer

[61] critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease

[62] herbal medicine goshajinkigan prevents paclitaxel-induced mechanical allodynia without impairing antitumor activity of paclitaxel

[63] synthetic studies towards d-modified paclitaxel analogues

[64] paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract

[65] efficacy and safety of paclitaxel, ifosfamide and cisplatin as first-line treatment on patients with intermediate- or poor-risk advanced testicular cancer

[66] paclitaxel reduces formation of hypertrophic scars in the rabbit ear model

[67] perda visual irreversível após uso de paclitaxel

[68] increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube

[69] nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma

[70] styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model

[71] health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and s-1 plus radiotherapy in patients with metastatic pancreatic cancer

[72] targeting metastatic breast cancer with ang1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (bbb)

[73] a near-complete response to treatment with gemcitabine plus nab®-paclitaxel in a patient with metastatic pancreatic cancer and poor performance status: a case report

[74] synthesis, structural characterization, and preclinical efficacy of a novel paclitaxel-loaded alginate nanoparticle for breast cancer treatment

[75] enhancement of radiotherapeutic efficacy by paclitaxel-loaded ph-sensitive block copolymer micelles

[76] vitrification of mouse mii oocytes: developmental competency using paclitaxel

[77] nonconvulsive status epilepticus secondary to paclitaxel administration

[78] synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid)

[79] paclitaxel-eluting stent (pes) versus everolimus-eluting stent (ees) in insulin requiring diabetics – are the results different?

[80] electrochemical behavior of paclitaxel and its determination at glassy carbon electrode

[81] lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to c6 glioma cells with p-gp inhibition and its tumor targeting

[82] effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study

[83] intensified neoadjuvant chemotherapy with nab-paclitaxel plus gemcitabine followed by folfirinox in a patient with locally advanced unresectable pancreatic cancer

[84] Dual drug delivery system of RAPTA-C and paclitaxel based on fructose coated nanoparticles for metastatic cancer treatment.

[85] Resistance of Breast Cancer Cells to Paclitaxel Elucidated